Stocktoria
Travere Therapeutics, Inc. TVTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2003-07-23
Travere Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 7,644,789 | $62.8M |
| RENAISSANCE TECHNOLOGIES LLC | 1,966,779 | $58.4M |
| TWO SIGMA INVESTMENTS, LP | 1,508,259 | $44.8M |
| D. E. Shaw & Co., Inc. | 836,544 | $24.9M |
| CITADEL ADVISORS LLC | 480,664 | $14.3M |
| AQR CAPITAL MANAGEMENT LLC | 305,412 | $9.1M |
| MILLENNIUM MANAGEMENT LLC | 20,000 | $594,200 |
Source: SEC EDGAR filings · CIK 0001438533 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.